Demographics of control and sarcoidosis groups
| Control subjects | Subjects with sarcoidosis | p-value | |
| Total subjects n | 27 | 14 | |
| Age years, median | 53.0 | 60.5 | 0.3355 |
| Sex n | 0.7337 | ||
| Female | 10 | 10 | |
| Male | 17 | 4 | |
| Race n | 0.0005 | ||
| Black | 2 | 9 | |
| White | 18 | 5 | |
| Asian | 1 | 0 | |
| Other | 6 | 0 | |
| Body mass index kg·m−2, median | 26.1 | 31.84 | 0.0319 |
| Days between vaccine dose, mean | 21.3 | 20.9 | 0.0793 |
| Days between 1st vaccine and V2D7, mean | 6.9 | 6.9 | 0.4939 |
| Days between 1st vaccine and M6, mean | 180.9 | 192.6 | 0.0575 |
V2D7: 7 days after vaccine dose 2 (4 weeks after 1st dose); M6: month 6 time point.